Alzheimers therapy (Myriad)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAlzheimers therapy (Myriad)
Drug Alias NameAbeta42 lowering agents (Myriad/ Mayo Clinic)Alzheimers disease therapeutics (Myriad/ Mayo Clinic)amyloid beta 42 lowering agents (Myriad/ Mayo Clinic)MPI-423948MPI-442690 +[8] 
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyriad Genetics IncMayo Clinic
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A